To study the regulatory mechanisms and efficacy of stem cell therapy in experimental models and in clinical contexts
We aim to evaluate the efficacy and safety of stent cell therapy in experimental models of acute and chronic ischemia.
To perform experimental models of neointimal hyperplasia, endothelialization, vascular inflammation and thrombosis
We aim to assess the inflammatory response leading to thrombosis and endothelial healing after coronary injury or therapeutic procedures in experimental models.
To evaluate the influence of hormonal factors, gender and aging in ischemic heart disease
The objective of this research line is to determine potential factors related to aging in ischemic heart disease experimental models .
To design experimental and clinical studies to evaluate the performance of novel devices and strategies to treat coronary artery disease, including chronic and acute coronary syndromes, cardiogenic shock and cardiac arrest
We aim to test potential new therapeutic devices and strategies by designing clinical trials in patients suffering from acute coronary syndromes, cardiogenic shock and/or cardiac arrest.
To evaluate neurohormonal activation, fibrotic process, genetic and environmental factors associated with ventricular remodeling in dilated cardiomyopathy
We aim to determine neurohormonal, genetic and environmental factors that are related to the development of ventricular remodeling in patients with dilated cardiomyopathy.
To determine the safety, efficacy and efficiency of new transcatheter and minimally invasive devices to treat structural and congenital heart disease and the role of imaging techniques
The goal of this project is to test the safety and efficacy of new therapeutic devices in order to treat structural and congenital cardiac defects in a minimally invasive way.
To evaluate new pharmacological and invasive treatments for pulmonary hypertension
The goal of this project is to test the safety and efficacy of new therapeutic approaches (pharmacological and devices) to treat pulmonary hypertension.